Breast Cancer at a Glance
Bahaty Riogi1,2, Ronald Wasike3
1.Kisii Teaching and Referral Hospital
2.International Breast Oncoplastic Surgery Fellow- St Helens and Knowsley Teaching Hospital, Liverpool.
3. Aga Khan University Hospital, Nairobi
Correspondence to: Bahaty Riogi. P.O Box 13449-00100 Nairobi, Kenya. Email: email@example.com
Breast cancer (BC) is the most common female malignancy worldwide, with a lifetime risk of 12% for an average woman (1). In East Africa, BC is among the top three diagnosed cancers, however with increasing awareness, it will likely become the most common oncological diagnosis as already seen in Kenya (2, 3). Recent regional studies show BC to be prevalent in younger patients (below 50 years), a trend consistent since 2008 (3-5). Globally the mortality of breast cancer has decreased over the last half a century due to screening and advancement in treatment. Through screening programs BC is diagnosed early, leading to higher survival rates. Even with the advantages of increased survival and reduced mortality, screening is not without harm; it may lead to false positives, anxiety, costs, over-diagnosis of non-malignant lesions and over-treatment.
Keywords: Breast Cancer, Cancer Screening Ann Afr Surg 2018; 15 (3)
Conflicts of Interest: Bahaty Riogi is the Associate Editor of the Annals of African Surery
© 2018 Author. This work is licensed under the Creative Commons Attribution 4.0 International License.